Transdermal application - the Matrifen® pain patch from Nycomed

Matrifen® with transdermal application is indicated for patients with severe chronic pain such as cancer pain or low back pain.

Transdermal application The Matrifen® pain patch from Nycomed has transdermal application of fentanyl to relieve pain in patients with prolonged or chronic severe pain.

>> Information on the transdermal application patch

Matrifen® with its transdermal application and membrane controlled release is a 72 hour or 3 day patch with a skin friendly silicone adhesion layer, that sticks well to the surface of the skin.

The efficient and advanced fentanyl patch technology with transdermal application provides pain relief for cancer related as well as non cancer related pains and the lower drug load adds to a higher degree of safety and lower environmental burden.

About Nycomed
Nycomed is driving a new way of providing pharmaceutical products in Europe. Physicians are seeking new treatments that make a clear medical difference. But traditional pharmaceutical companies, with a single research department, are finding it harder to meet this need.

Nycomed, by contrast, can access the work of thousands of companies dedicated to research, and choose to make available the most innovative treatments.

Chronic non cancer pain | Advanced matrix fentanyl patch technology | Respiratory depression